Rodolphe Barrangou

Rodolphe Barrangou Ph.D. is the Klaenhammer Distinguished Professor at North Carolina State University. Rodolphe spent 9 years in R&D and M&A at Danisco and DuPont, and has been at NC State since 2013. Dr. Barrangou earned a BS in Biological Sciences from Rene Descartes University, France, a MS in Biological Engineering from the University of Technology in Compiegne, France, a MS in Food Science from NC State, a PhD in Genomics from NC State and a MBA from the University of Wisconsin-Madison. Dr. Barrangou is a co-founder of Intellia Therapeutics, Locus Biosciences, TreeCo, Ancilia Biosciences and CRISPR Biotechnologies, an advisor to the KiTua Fund, HoofPrint Biome, Inari Ag, Provaxus, and the Editor in Chief of the CRISPR Journal.